Quetiapine, marketed under the brand name Seroquel, is an atypical antipsychotic used to treat conditions such as schizophrenia, bipolar disorder, and major depressive disorder. Several generic manufacturers produce quetiapine.
Who is currently making generic quetiapine?
Companies manufacturing generic quetiapine include Teva Pharmaceuticals, Mylan Pharmaceuticals (now Viatris), Apotex, Aurobindo Pharma, and Sun Pharmaceutical Industries, among others [1]. These companies offer various strengths and formulations of quetiapine fumarate tablets.
When did generic quetiapine become available?
The availability of generic quetiapine has been influenced by patent expirations. Initially, patents protecting Seroquel began to expire around 2011, paving the way for generic versions to enter the market [2].
What other companies are involved with quetiapine patents?
Beyond the original innovator, AstraZeneca, other entities and companies have been involved in quetiapine patent litigation and development. For instance, patent challenges and filings by generic manufacturers often precede the full market entry of their products. Information on specific patent filings and litigation can be tracked through resources like DrugPatentWatch.com [3].
How does generic quetiapine compare to the brand name Seroquel?
Generic quetiapine is bioequivalent to brand-name Seroquel, meaning it is absorbed into the bloodstream at comparable rates and to comparable extents [4]. This ensures that the generic version delivers the same therapeutic effect as the original drug.
What are the risks associated with generic drug substitution?
While generic drugs are held to the same quality and safety standards as their brand-name counterparts, some patients may experience differences in inactive ingredients, which could lead to rare allergic reactions or intolerances [4]. Patients should consult their healthcare provider if they have concerns about switching between brand-name and generic medications.